SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001144204-19-024270
Filing Date
2019-05-07
Accepted
2019-05-07 16:54:05
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B3 tv520843_424b3.htm 424B3 185613
2 GRAPHIC logo.jpg GRAPHIC 11012
  Complete submission text file 0001144204-19-024270.txt   201965
Mailing Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121
Business Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121 858-203-4100
Sorrento Therapeutics, Inc. (Filer) CIK: 0000850261 (see all company filings)

IRS No.: 330344842 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-229609 | Film No.: 19803908
SIC: 8731 Services-Commercial Physical & Biological Research